Royalty Pharma CEO acquires 42,209 award shares

The award settlement left Royalty Pharma's CEO with 1,350,029 directly held Class A Ordinary Shares.

Available on EDGAR 11/06/2026 - 04:16 PM EST Accepted by SEC EDGAR 11/06/2026 - 04:15 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Royalty Pharma plc CEO and Chairman Pablo G. Legorreta acquired 42,209 Class A Ordinary Shares on November 4, 2026, in an exempt acquisition connected with settlement of Equity Performance Awards under Rule 16b-3. His directly held position following the acquisition was 1,350,029 Class A Ordinary Shares. Separately, Legorreta and family vehicles he controls hold 73,195,660 Class B Ordinary Shares and 13,356,742 Class E Ordinary Shares of Royalty Pharma Holdings Ltd., exchangeable into the same respective numbers of Class A Ordinary Shares; the Class E shares are subject to vesting conditions.

Insider Trade Summary

Grant/Award: 42,209 shares

Grant/Award 1 txn

Insider Legorreta Pablo G.

Role CEO, Chairman of the Board

Type	Security	Shares	Price	Value
Grant/Award	Class A Ordinary Shares F1	42,209	$0.00	$0.00
Holding	Class A Ordinary Shares	--	--	--
Holding	Class A Ordinary Shares	--	--	--
Holding	Class A Ordinary Shares	--	--	--
Holding	Class A Ordinary Shares	--	--	--
Holding	Class A Ordinary Shares	--	--	--
Holding	Class A Ordinary Shares	--	--	--
Holding	Class A Ordinary Shares	--	--	--
Holding	Class A Ordinary Shares	--	--	--
Holding	Class A Ordinary Shares	--	--	--
Holding	Class A Ordinary Shares	--	--	--
Holding	Class A Ordinary Shares	--	--	--

Holdings After Transaction: Class A Ordinary Shares — 1,350,029 shares (Direct); Class A Ordinary Shares — 1,040,410 shares (Indirect, By Legorreta Children 2002 Trust); Class A Ordinary Shares — 901,590 shares (Indirect, By GST-Exempt Legorreta 2012 Family Trust); Class A Ordinary Shares — 600,000 shares (Indirect, By Legorreta 2023 SR Trust); Class A Ordinary Shares — 460,139 shares (Indirect, By Legorreta Investments LLC); Class A Ordinary Shares — 292,190 shares (Indirect, By Tata MC 35 Ltd.); Class A Ordinary Shares — 123,310 shares (Indirect, By IRRA); Class A Ordinary Shares — 118,500 shares (Indirect, By SEP/IRA); Class A Ordinary Shares — 41,306 shares (Indirect, By GST-Exempt Legorreta 2020 Family Trust); Class A Ordinary Shares — 10,000 shares (Indirect, By Son); Class A Ordinary Shares — 10,000 shares (Indirect, By Daughter); Class A Ordinary Shares — 6,930 shares (Indirect, By Spouse)

Footnotes (1)

1. F1. Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.

Key Figures

Class A Ordinary Shares acquired: 42,209 shares Direct Class A Ordinary Shares following acquisition: 1,350,029 shares Class B Ordinary Shares: 73,195,660 shares +1 more

4 metrics

Class A Ordinary Shares acquired 42,209 shares November 4, 2026; settlement of Equity Performance Awards

Direct Class A Ordinary Shares following acquisition 1,350,029 shares Pablo G. Legorreta's reported position

Class B Ordinary Shares 73,195,660 shares Held by Legorreta and family vehicles he controls; exchangeable into the same number of Class A Ordinary Shares

Class E Ordinary Shares 13,356,742 shares Held by Legorreta and family vehicles he controls; exchangeable into the same number of Class A Ordinary Shares and subject to vesting conditions

Key Terms

Rule 16b-3, Equity Performance Awards, Class B Ordinary Shares, vesting conditions

4 terms

Rule 16b-3 regulatory

"pursuant to Rule 16b-3"

Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.

Equity Performance Awards financial

"settlement of Equity Performance Awards"

Class B Ordinary Shares financial

"73,195,660 Class B Ordinary Shares"

Class B ordinary shares are a type of ownership stake in a company that typically come with different voting rights or privileges compared to other share classes. For investors, they represent a way to hold part of the company’s value and influence its decisions, often with fewer voting rights than Class A shares. Understanding these shares helps investors assess their level of control and potential returns within a company.

vesting conditions financial

"Class E Ordinary Shares are subject to vesting conditions"

Vesting conditions are the rules that determine when someone earning company stock or stock options actually gains the right to keep or sell them, typically based on staying with the company for a set time or meeting performance targets. Think of it like keys that unlock gradually — some unlock by calendar date, others only after agreed milestones. Investors care because vesting shapes management incentives, the timing of share sales, and the number of shares that can enter the market, which can affect a company's valuation and ownership mix.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RPRX shares did CEO Pablo G. Legorreta acquire?

Pablo G. Legorreta, Royalty Pharma's CEO and Chairman, acquired 42,209 Class A Ordinary Shares on November 4, 2026, in an exempt acquisition connected with settlement of Equity Performance Awards. His direct holdings afterward were 1,350,029 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Legorreta Pablo G.

(Last) (First) (Middle)

C/O ROYALTY PHARMA PLC

110 E. 59TH STREET

(Street)

NEW YORK NEW YORK 10022

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Royalty Pharma plc [ RPRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO, Chairman of the Board

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Ordinary Shares	11/04/2026		A		42,209(1)	A	$0	1,350,029	D
Class A Ordinary Shares								1,040,410	I	By Legorreta Children 2002 Trust
Class A Ordinary Shares								901,590	I	By GST-Exempt Legorreta 2012 Family Trust
Class A Ordinary Shares								600,000	I	By Legorreta 2023 SR Trust
Class A Ordinary Shares								460,139	I	By Legorreta Investments LLC
Class A Ordinary Shares								292,190	I	By Tata MC 35 Ltd.
Class A Ordinary Shares								123,310	I	By IRRA
Class A Ordinary Shares								118,500	I	By SEP/IRA
Class A Ordinary Shares								41,306	I	By GST-Exempt Legorreta 2020 Family Trust
Class A Ordinary Shares								10,000	I	By Son
Class A Ordinary Shares								10,000	I	By Daughter
Class A Ordinary Shares								6,930	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.

Remarks:

In addition to the Class A Ordinary Shares disclosed above, the Reporting Person and family vehicles controlled by the Reporting Person hold 73,195,660 Class B Ordinary Shares exchangeable into 73,195,660 Class A Ordinary Shares and 13,356,742 Class E Ordinary Shares of Royalty Pharma Holdings Ltd ("RPH") exchangeable into 13,356,742 Class A Ordinary Shares. Class E Ordinary Shares of RPH are subject to vesting conditions.

	/s/ Sean Weisberg, as Attorney-in-Fact for Pablo G. Legorreta	11/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)